z-logo
open-access-imgOpen Access
Low prevalence of transmitted HIV-1 drug resistance detected by a dried blood spot (DBS)-based next-generation sequencing (NGS) method in newly diagnosed individuals in Cameroon in the years 2015–16
Author(s) -
Herbert A Mbunkah,
Alex Marzel,
Stefan Schmutz,
Yik Lim Kok,
Osvaldo Zagordi,
Mohaned Shilaih,
Ndi N Nsanwe,
Eyongetah Tabenyang Mbu,
Lydia M Besong,
Bella A Sama,
Emmanuel Orock,
Roger D. Kouyos,
Huldrych F. Günthard,
Karin J. Metzner
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky103
Subject(s) - dried blood spot , human immunodeficiency virus (hiv) , drug resistance , medicine , dried blood , drug , dna sequencing , virology , multi drug resistant , biology , microbiology and biotechnology , pharmacology , genetics , dna , chemistry , chromatography
To determine the most recent prevalence, transmission patterns and risk factors of transmitted drug-resistance mutations (TDRMs) in Cameroon, we initiated a multicentre study monitoring HIV-1 drug resistance in newly HIV-1-diagnosed individuals using a novel next-generation sequencing (NGS) assay applicable to fingerprick dried blood spot (DBS) samples.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom